AURORA, Colo. -- Among those at low-risk for preterm birth, a blood-based biomarker screening test during the second ...

Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

The team will look at new and existing blood tests, looking at a range of dementia types including Alzheimer’s disease, ...

A new study suggests that certain substances in the blood may help identify people with a type of irregular heartbeat called ...

US researchers have revealed the fingerprints of sudden infant death syndrome (SIDS) within blood samples, which could open the door to simple tests to identify babies at risk.

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

While clinical factors and imaging are useful in identifying patients at risk for PSCID, blood-based biomarkers are sorely needed to provide cost-effective identification and prognostication for ...

Explore how psychosocial and physical stress affects cfDNA release in blood and saliva. Discover gender differences and ...

Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker ...